Navigation Links
SpineSmith to Present at the 5th Annual Stem Cell Summit
Date:2/15/2010

AUSTIN, Texas, Feb. 15 /PRNewswire/ -- Dr. Robert Johnson, MD, of Neurosurgical Associates of San Antonio, is presenting at the 5th Annual Stem Cell Summit in New York on February 16, 2010. Dr. Johnson will be presenting his most recent data proving the efficacy of point of care adult stem cell therapies in spine surgery.  Point of care technology utilizes the patient's own cells derived from bone marrow to inhibit bone growth in spinal fusion procedures.  Dr. Johnson believes promoting cell therapy utilizing the patient's own cells will change the future landscape of medicine.  

"The use of autologous stem cells is revolutionizing medical care in both the prevention and treatment of spinal disorders," said Johnson.

The annual Stem Cell Summit brings together the leading medical, financial and scientific innovators within the rapidly expanding field of regenerative medicine. SpineSmith has been an avid attendee and sponsor of the Stem Cell Summit for numerous years and built a business around the future of regenerative medicine.  SpineSmith launched Celling Technologies to research and develop cell therapies through the collaboration of scientists, engineers and medical providers in a wide spectrum of applications including spine, orthopedics, trauma, plastics, cardiovascular and disease.

Dr. James Poser, Vice President of Regenerative Medicine for Celling Technologies, believes the future of regenerative medicine is upon us and the science has quickly pushed technology to deliver results-based medicine.  Dr. Poser believes point of care technologies are quickly becoming a source for consistent, reliable and predictable results for cell therapies.

"It is through collaborative efforts like those with Dr. Johnson that Celling Technologies intends to rigorously investigate and expand the opportunities for the effective use of a patient's own cells in regenerative medicine.  The Stem Cell Summit has become a preeminent forum for sharing and discussing these developments, and we look forward to participating in this and future Summit meetings," said Poser.

About SpineSmith Partners, LP

SpineSmith Partners, LP is dedicated to creating better ways to facilitate and accelerate the healing of spinal disorders through integration of innovative medical devices and biologic technologies. SpineSmith designs, develops, and markets implants and biologics for surgical fixation, correction, and tissue regeneration of the spine.

About Celling Technologies

Celling Technologies, a SpineSmith Partners company, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine.  Celling's product offering focuses on autologous adult stem cell therapies and the devices and services that complement these procedures.  

About Neurosurgical Associates of San Antonio

Neurosurgical Associates of San Antonio provides comprehensive spine care across a full spectrum of neurologic and spinal surgery.   Neurosurgical Associates of San Antonio is committed to providing state-of-the-art neurosurgical and spine care as well as the highest quality of care, compassion and excellence to patients.

www.spinesmithusa.com

www.cellingtechnologies.com

SOURCE SpineSmith Partners, LP

RELATED LINKS
http://www.spinesmithusa.com
http://www.cellingtechnologies.com

'/>"/>

SOURCE SpineSmith Partners, LP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement
2. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
3. SIU To Present System Technology & Innovation Expo March 30
4. YM BioSciences presents CYT387 and CYT997 data at international cancer conference
5. European research initiative EUREKA presented at Research & Technology for the first time
6. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
7. NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference
8. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
9. Interleukin Genetics to Present at the 12th Annual BIO CEO Conference
10. The Advisory Board Company to Present at Upcoming Conferences
11. Soligenix to Present at 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , ... January 11, 2017 , ... Back pain relief ... No Shots and No Surgery for positive back pain relief for WAR members. , ... results worldwide and could be life changing for millions suffering from chronic back pain. ...
(Date:1/11/2017)... , PITTSBURGH and BENGALURU, ... N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: ... and Drug Administration (FDA) has accepted Mylan,s biologics license ... filing through the 351(k) pathway. This product is a ... treat certain HER2-positive breast cancers. The anticipated FDA goal ...
(Date:1/11/2017)... 2017  GenVec, Inc. (NASDAQ: GNVC ... that its chief scientific officer, Douglas E. ... platform for translational development of innovative gene and ... upcoming Phacilitate Cell & Gene Therapy World 2017 ... Dr. Brough,s presentation will highlight the utility of ...
(Date:1/11/2017)... ... January 11, 2017 , ... KBioBox llc ... with Poseida Therapeutics Inc, the San Diego based specialist in gene and cell ... KBioBox in order to harness KBioBox’s powerful BioEngine Algorithms which do not compromise ...
Breaking Biology Technology:
(Date:12/15/2016)... ... Research and Markets has announced the addition of the "Global ... The report forecasts the global military biometrics market to grow at a ... has been prepared based on an in-depth market analysis with inputs from ... over the coming years. The report also includes a discussion of the ...
(Date:12/12/2016)... CLEVELAND , Dec. 12, 2016  Researchers ... commercial possibilities for graphene by combining the material ... a highly sensitive pressure detector able to sense ... of a small spider.  The ... and can be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... TEL AVIV, Israel , December 7, 2016 ... year with the expansion of its patent portfolio, which grew to over ... , , ... led by its recently filed patent entitled " System, Device, ... which covers technology that enables device makers to forego costly hardware components ...
Breaking Biology News(10 mins):